1404. Plasma haemostatic potential of haemodialysis patients assessed by thrombin generation assay: hypercoagulability in patients with vascular access thrombosis.
1403. Decreased thrombomodulin mRNA expression on peripheral monocytes in disseminated intravascular coagulation patients relates to poor outcomes: the ex vivo effects of lipopolysaccharide and thrombin on monocyte thrombomodulin and CD14 mRNA.
Hong SK, Kim JE, Han KS, Kim HK.
Thromb Res. 2013 Sep;132(3):392-7. doi: 10.1016/j.thromres.2013.07.025. Epub 2013 Aug 3.Link
1402. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
Choi Q, Kim JE, Hyun J, Han KS, Kim HK.
Thromb Res. 2013 Jul;132(1):e70-5. doi: 10.1016/j.thromres.2013.05.015. Epub 2013 Jun 13.Link
1401. Serum des-R prothrombin activation peptide fragment 2: a novel prognostic marker for disseminated intravascular coagulation.
Chung S, Kim JE, Kim HK, Yeon EH, Shin YS, Kim CW.
Thromb Res. 2013 Jun;131(6):547-53. doi: 10.1016/j.thromres.2013.04.015. Epub 2013 May 7.Link
1400. Coagulation proteins influencing global coagulation assays in cirrhosis: hypercoagulability in cirrhosis assessed by thrombomodulin-induced thrombin generation assay.
Youngwon N, Kim JE, Lim HS, Han KS, Kim HK.
Biomed Res Int. 2013;2013:856754. doi: 10.1155/2013/856754. Epub 2013 Feb 21.Link
1399. Influence of coagulation and anticoagulant factors on global coagulation assays in healthy adults.
Kim SY, Kim JE, Kim HK, Kim I, Yoon SS, Park S.
Am J Clin Pathol. 2013 Mar;139(3):370-9. doi: 10.1309/AJCPC5C4AGFRDKMX.Link
1398. Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis.